Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol
about
Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and careMorphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosisCrystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibioticsRepurposing clinically approved cephalosporins for tuberculosis therapyRifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest EthiopiaAnti tuberculosis drug resistance in west of iran.Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.Emerging therapeutic targets in tuberculosis: post-genomic era.Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.In vitro susceptibility of Mycobacterium tuberculosis isolates to an oral carbapenem alone or in combination with β-lactamase inhibitorsDeveloping New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
P2860
Q27005623-D9164828-684D-45A2-AFD1-0E7DD07ED935Q28487277-ACA2523F-4C8E-42B1-8703-A8AA7291F4A9Q28487411-D0B05D31-3414-4438-B138-4E88EDF74589Q28828720-F32B8553-9A47-4D06-997E-EEA1948F8674Q33812641-7A87781F-A427-4BBB-93E4-B9167668C766Q34101408-411E5906-735E-4528-BB0F-FAD344AECE7DQ34272070-FB942754-D6BC-47BA-9AFD-0BEC9F1016EBQ34568947-2E164D1A-14A1-4CBB-BAC1-2675644709ACQ35669319-C2A6E35D-D8CF-4EE6-87D2-AF5AD078F969Q35849799-4DABDB5C-DC82-4D8A-A5CE-FA2D05AF1E33Q38973367-38A07A54-7D58-4516-9B95-0FBCB193599AQ39967041-C2083F18-7A8A-44E3-B79C-1E2D2258DF7BQ40675039-04E1CCB5-EDB9-4FDA-AA03-812B8668C079Q42109610-A58A6097-FE8C-47D5-BED1-009D9F939164Q42278779-32EAA113-3E7F-4651-A9BF-5F7082772597Q46604521-0100CCF6-1D26-41C9-AE99-31CA8296F024
P2860
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@ast
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@en
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@nl
type
label
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@ast
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@en
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@nl
prefLabel
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@ast
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@en
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@nl
P3181
P356
P1476
Susceptibility of multidrug-re ...... clavulanic acid and ethambutol
@en
P2093
P304
P3181
P356
10.1093/JAC/42.6.735
P407
P577
1998-12-01T00:00:00Z